Ionis Pharmaceuticals | IONS - Current Liabilities


Ionis Pharmaceuticals reported $783M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Agios Pharmaceuticals USD 82.21M 7.45M Dec/2025
Alnylam Pharmaceuticals USD 1.47B 89.13M Dec/2025
Arrowhead Research USD 347.42M 151.94M Dec/2025
Astellas Pharma JPY 1.32T 873M Dec/2025
BioCryst Pharmaceuticals USD 190.24M 13.08M Sep/2025
BioMarin Pharmaceutical USD 759.03M 39.41M Dec/2025
Celltrion KRW 4.01T 343.96B Sep/2025
Cspc Pharmaceutical CNY 10.11B 478.47M Jun/2025
Deva Holding AS TRY 6.43B 1.18B Sep/2023
Divis Laboratories Ltd INR 17.28B 2.76B Sep/2025
Esperion Therapeutics USD 359.03M 60.24M Sep/2025
Exelixis USD 405.64M 31.86M Dec/2025
Halozyme Therapeutics USD 177.09M 660.14M Dec/2025
Ionis Pharmaceuticals USD 783M 120.46M Dec/2025
Kangmei Pharma CNY 5.81B 57.93M Sep/2025
Knight Therapeutics CAD 118.15M 12.32M Sep/2024
Laboratorios Farma EUR 199.84M 121.75M Dec/2023
Malin Corporation EUR 1000K 500K Dec/2024
Medical Developments International AUD 5.56M 2.26M Dec/2025
Moderna USD 1.99B 306M Dec/2025
Nektar Therapeutics USD 66.34M 5.05M Sep/2025
Neuren Pharmaceuticals AUD 4.34M 3.58M Dec/2025
Neurocrine Biosciences USD 743.4M 105.4M Dec/2025
Novartis USD 32B 286M Sep/2025
Omeros USD 85.5M 2.28M Jun/2025
OPKO Health USD 169.32M 1.86M Sep/2025
Organigram Holdings CAD 126.16M 18.88M Sep/2025
Ovoca Bio EUR 2.44M 1.1M Jun/2022
Pfizer USD 36.6B 1.13B Sep/2025
Pharma Mar EUR 93.88M 4.94M Dec/2025
PTC Therapeutics USD 968.43M 102.18M Dec/2025
Qiagen NV USD 512.14M 461.26M Dec/2025
Regeneron Pharmaceuticals USD 4.37B 56.7M Dec/2025
Roche Holding CHF 28B 421M Dec/2025
Sarepta Therapeutics USD 1.1B 173.86M Dec/2025
Sartorius EUR 1.81B 254.3M Sep/2025
Sino Biopharmaceutical CNY 24.85B 5.29B Jun/2025
Tilray USD 280.3M 18.13M Mar/2025
Ultragenyx Pharmaceutical USD 340.02M 46.78M Sep/2025
Vertex Pharmaceuticals USD 3.86B 614.1M Dec/2025
Zz Pientze Pharmaceu CNY 2.14B 1.06B Sep/2025